Can Recurrent Episodes Occur Multiple Times Per Day for Months or Years in MCAS?
No, true mast cell activation syndrome (MCAS) is characterized by episodic, not continuous or multiple daily attacks, and persistent daily symptoms should prompt evaluation for alternative diagnoses rather than MCAS. 1
Key Diagnostic Feature: Episodic Nature
The defining characteristic of MCAS is recurrent episodic systemic anaphylaxis affecting at least 2 organ systems concurrently, not continuous or multiple daily symptoms. 1 The AAAAI guidelines explicitly state that:
- Persistent symptoms should direct clinicians to a different underlying diagnosis, such as chronic urticaria or poorly controlled asthma 1
- MCAS presents with spontaneous episodic signs and symptoms, meaning discrete attacks with periods of relative wellness between episodes 1
- The episodes must be associated with acute increases in mediator levels (tryptase rising >20% + 2 ng/mL from baseline within 1-4 hours of symptom onset) 1, 2
Critical Diagnostic Pitfall
The most common error is misdiagnosing patients with chronic, persistent, or multiple daily symptoms as having MCAS when they actually have other conditions. 3 A prospective real-life study found that:
- Only 2% of patients with suspected MCAS actually met diagnostic criteria 3
- 53% of patients self-diagnosed based on internet information 3
- Patients reported up to 87 different symptoms, mostly fatigue, musculoskeletal pain, and abdominal pain—symptoms that are nonspecific and chronic rather than episodic 3
- Depression and anxiety disorders were frequent comorbidities (23 patients each), with 65% having pathological anxiety/depression scores linked to high disease impact 3
What True MCAS Episodes Look Like
Genuine MCAS episodes are characterized by:
- Discrete attacks with clear onset and resolution, not continuous symptoms 1, 4
- Concurrent involvement of at least 2 organ systems during each episode (e.g., syncope with wheezing, diarrhea with flushing) 1
- Measurable biochemical evidence during the acute episode showing mast cell mediator release 1, 2
- Symptom-free or relatively asymptomatic intervals between episodes 1
Management Implications
If a patient reports multiple episodes daily for extended periods:
- Reconsider the diagnosis entirely before escalating mast cell-targeted therapy 1, 3
- Evaluate for functional gastrointestinal disorders, chronic pain syndromes, anxiety disorders, or other conditions that present with chronic symptoms 3, 5
- Remember that H1 and H2 antihistamines work better as prophylaxis than acute treatment and are most effective for true episodic symptoms 1
- Only 5% of suspected MCAS patients show complete response to mast cell-targeted treatment, further supporting that most do not have true MCAS 3
The pattern of symptoms matters as much as the symptoms themselves—episodic attacks are the hallmark, not chronic daily suffering. 1, 4